NEW YORK, April 24, 2025 /PRNewswire/ -- TB Alliance applauds a new milestone in the fight against drug-resistant tuberculosis (DR-TB): a 25% price reduction for pretomanid, a key component of the ...

Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-19¹. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for infecting ...

The Union Zimbabwe Trust (UZT) with financial assistance from the Stop TB Partnership has handed over the recently completed REACH project to the Health and Child Care ministry. In 2021, UZT was among ...

The World Health Organization has recommended countries move toward shorter treatment regimens for certain people with drug-resistant tuberculosis (DR-TB), including those co-infected with HIV, ...

Mumbai: In order to meet the Centre’s ‘End Tuberculosis by 2025’ target, the Brihanmumbai Municipal Corporation (BMC) has now roped in private hospitals to treat drug-resistant tuberculosis.

A patient we'll call Juliet is a young woman you wouldn't have noticed if you had happened upon her in the market or on a bus in the African country where she lived. She looks healthy. But she isn’t.

Globally, out of the half-a-million people who develop DR-TB (drug-resistant-tuberculosis) each year, India currently contributes over 25 per cent of the burden. On an annual basis, there are at over ...

An evaluation report released today by Doctors Without Borders (MSF) charts progress towards decentralizing services for patients with drug-resistant tuberculosis (DR-TB) in South Africa's ...